Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations (2018)
Hirata, Rosario Dominguez Crespo 
; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: DOENÇAS METABÓLICAS, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-25 art. e01005, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001005. Acesso em: 10 out. 2024.APA
Hirata, R. D. C., Cerda, A., Genvigir, F. D. V., & Hirata, M. H. (2018). Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, 54, 1-25 art. e01005. doi:10.1590/s2175-97902018000001005NLM
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 out. 10 ] Available from: https://doi.org/10.1590/s2175-97902018000001005Vancouver
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 out. 10 ] Available from: https://doi.org/10.1590/s2175-97902018000001005
